Principal Financial Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
Other funds holding PRVB
Principal Financial Group's PRVB Position: Q2 2023 in Review
Principal Financial Group sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 306,298 shares — an estimated $7.38M sold.
Principal Financial Group first reported a position in PRVB in Q2 2020 and held it in 9 quarters. The position peaked at $7.38M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.
- Principal Financial Group reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Principal Financial Group sold 306,298 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $7.38M.
- Principal Financial Group first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
- Principal Financial Group's Provention Bio, Inc. Common Stock position peaked at $7.38M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.
Based on Principal Financial Group's 13F filing for Q2 2023, filed 7 Aug 2023.